Related Experiment Video
Updated: Jun 6, 2026

06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Design of a predictive targeting error simulator for MRI-guided prostate biopsy
Shachar Avni1, Siddharth Vikal, Gabor Fichtinger
1School of Computing, Queen's University, Kingston, ON, Canada.
Summary
This study introduces a prostate biopsy simulator to assess targeting accuracy. Results suggest segmentation errors up to 4-5 mm are tolerable for small tumors, guiding future clinical trials.
Area of Science:
- Medical Imaging
- Computational Biology
- Surgical Simulation
Background:
- Multi-parametric MRI offers superior quality compared to Ultrasound (US) for prostate imaging.
- Current standard prostate biopsy procedures utilize US, facing limitations in accuracy.
- Surface-based registration is a simpler alternative to deformable registration for aligning pre-operative and intra-operative prostate volumes.
Purpose of the Study:
- To introduce and detail a novel, interactive simulator for validating prostate biopsy targeting accuracy.
- To quantify the impact of segmentation errors on registration and biopsy targeting.
- To establish preliminary tolerable limits for segmentation errors in the context of small tumor detection.
Main Methods:
- Development of a fully interactive and customizable simulator for prostate biopsy registration.
- Implementation of a segmentation error introduction algorithm using polar curves and natural cubic spline interpolation.
- Simulation of organ deformation, segmentation, and targeting with user-defined parameters.
Main Results:
- The simulator quantifies targeting errors resulting from simulated registrations between prostate volumes.
- Statistically realistic contouring errors are introduced via a novel algorithm.
- Preliminary simulations indicate a maximum tolerable segmentation error of 4-5 mm for a 5.0 mm small tumor.
Conclusions:
- The developed simulator provides a robust platform for validating prostate biopsy procedures.
- Segmentation accuracy is critical for accurate registration and biopsy targeting.
- Further validation through clinical trials is planned to confirm simulation findings.
